Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sun Pharma Share Price Live Updates: Sun Pharma's Impressive Monthly Returns
Sun Pharmaceutical receives credit ratings from CRISIL and ICRA
Sun Pharmaceutical Industries (Sun Pharma) announced that CRISIL has reaffirmed the rating of the company's long term bank facilities at CRISIL AAA and short term bank facilities and commercial paper at CRISIL A1+.
Sun Pharma Share Price Live Updates: Sun Pharma's beta highlights consistent performance
Sun Pharma gets relief in trademark case from High Court
The Bombay High Court has ruled in favour of Sun Pharmaceutical Industries. The court has restrained United Biotech from using a similar trademark. Sun Pharma's 'Octride' mark is protected. The dispute involves drugs for acromegaly and carcinoid tumours. The court found Sun Pharma had a stronger claim. This decision protects Sun Pharma's reputation and goodwill.
Sun Pharma, 5 stocks hit 52-week highs, rally up to 25% in a month
Sensex surged 940 points as six BSE 100 stocks hit 52-week highs, signalling strong bullish momentum. Stocks like Adani Ports, Nestle India and Sun Pharma led gains, supported by solid monthly performance and positive investor sentiment in a rising market
Sun Pharma Share Price Live Updates: Sun Pharma's Recent Trading Figures
Sun Pharma explores funding mix for $12 billion Organon deal
Global lenders are exploring various financing options for Sun Pharmaceutical Industries' proposed $12 billion acquisition of Organon & Co. The Indian drugmaker is considering swapping Organon bondholders into Sun Pharma debt and a potential euro-denominated bond. Additionally, Sun Pharma plans to raise $3 billion to $4 billion in offshore loans, with deal approvals anticipated by December.
Sun Pharma Share Price Live Updates: Sun Pharma's Current Market Price
Sun Pharma Share Price Live Updates: Sun Pharma's previous close stands at Rs 1808.3
Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — 4 May 2026
Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Reliance, Kotak Mahindra Bank, and Sun Pharma
Market end sharply lower; Nifty settles below 24,000 mark
Metal, PSU Bank and consumer durables shares declined while IT and Pharma stocks advanced.
Where to invest now: SBI MF prefers large caps, pharma, PSU banks
Ruchit Mehta, Head of Research at SBI Mutual Fund, prefers CDMO and hospital plays within pharma, citing stronger growth prospects over generics. He sees large caps as attractive on valuations, while midcaps require selectivity amid earnings risks. PSU banks may outperform in the near term due to stronger loan growth, but asset quality risks could emerge over the next 2–3 quarters if global disruptions persist.